Addition of human chorionic gonadotropin to clomiphene citrate ovulation induction therapy does not improve pregnancy outcomes and luteal function


Yilmaz B., Kelekci S., Savan K., Oral H., Mollamahmutoglu L.

FERTILITY AND STERILITY, vol.85, no.3, pp.783-786, 2006 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Editorial Material
  • Volume: 85 Issue: 3
  • Publication Date: 2006
  • Doi Number: 10.1016/j.fertnstert.2005.09.018
  • Journal Name: FERTILITY AND STERILITY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.783-786
  • Recep Tayyip Erdoğan University Affiliated: Yes

Abstract

In a randomized prospective study, 125 women with World Health Organization class II anovulation received 50 mg of clomiphene citrate alone (group A, n = 65) or 50 mg of clomiphene citrate plus hCG (group B, n = 60) in a total of 125 cycles during natural intercourse-advised cycles. There were no statistically significant differences between groups regarding pregnancy outcomes and midluteal P levels, but luteal phase length was longer in group A.